1. Home
  2. NVAX vs KAR Comparison

NVAX vs KAR Comparison

Compare NVAX & KAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • KAR
  • Stock Information
  • Founded
  • NVAX 1987
  • KAR 2006
  • Country
  • NVAX United States
  • KAR United States
  • Employees
  • NVAX N/A
  • KAR N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • KAR Retail-Auto Dealers and Gas Stations
  • Sector
  • NVAX Health Care
  • KAR Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • KAR Nasdaq
  • Market Cap
  • NVAX 1.3B
  • KAR 2.4B
  • IPO Year
  • NVAX 1995
  • KAR 2009
  • Fundamental
  • Price
  • NVAX $6.80
  • KAR $25.80
  • Analyst Decision
  • NVAX Buy
  • KAR Buy
  • Analyst Count
  • NVAX 5
  • KAR 4
  • Target Price
  • NVAX $16.60
  • KAR $24.00
  • AVG Volume (30 Days)
  • NVAX 5.2M
  • KAR 834.5K
  • Earning Date
  • NVAX 08-07-2025
  • KAR 08-06-2025
  • Dividend Yield
  • NVAX N/A
  • KAR N/A
  • EPS Growth
  • NVAX N/A
  • KAR N/A
  • EPS
  • NVAX 2.97
  • KAR 0.58
  • Revenue
  • NVAX $1,254,962,000.00
  • KAR $1,818,700,000.00
  • Revenue This Year
  • NVAX $56.85
  • KAR $1.93
  • Revenue Next Year
  • NVAX N/A
  • KAR $6.25
  • P/E Ratio
  • NVAX $2.29
  • KAR $44.50
  • Revenue Growth
  • NVAX 25.92
  • KAR 6.67
  • 52 Week Low
  • NVAX $5.01
  • KAR $15.44
  • 52 Week High
  • NVAX $17.81
  • KAR $25.80
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.68
  • KAR 77.56
  • Support Level
  • NVAX $6.23
  • KAR $22.09
  • Resistance Level
  • NVAX $6.90
  • KAR $23.10
  • Average True Range (ATR)
  • NVAX 0.30
  • KAR 0.57
  • MACD
  • NVAX 0.01
  • KAR 0.23
  • Stochastic Oscillator
  • NVAX 67.00
  • KAR 100.00

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About KAR OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

Share on Social Networks: